2022 Ljubljana, Slovenia

II-33 Xia Li
Population Pharmacokinetics and Exposure–Response Analyses of Daratumumab in Combination With Pomalidomide and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Wednesday 15:10-16:40